unknown
Stage
1
Investors
About
BioXplor develops AI-driven data analytics platforms to improve drug discovery and clinical trial efficiency, focusing on rare and inflammatory diseases as well as cancer by leveraging real-world evidence and advanced analytics.
Explore BioXplor's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.